Epclusa

Epclusa is a combination medication containing Sofosbuvir and Velpatasvir, used for treating chronic hepatitis C. This oral medication is designed to target the virus and support liver health.

Epclusa is primarily used for the treatment of chronic hepatitis C virus (HCV) infection. It works by targeting the virus to help manage the condition. The medication is often prescribed as part of a comprehensive treatment plan to support liver health and overall well-being.

Common effects of Epclusa may include fatigue, headache, and nausea. Some individuals might experience dizziness or insomnia. These effects can vary from person to person and are generally mild to moderate in nature.

Epclusa should be used under medical supervision. It is important to inform your healthcare provider about any other medications you are taking to avoid potential interactions. Regular monitoring may be required to ensure the medication is working effectively.

Epclusa can interact with certain medications, including those that affect liver enzymes. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.